Polarean Imaging Share Discussion Threads

[moontheloon] 05/3/2024 12:33

One looked like a duplicate tbh

[wetdream] 05/3/2024 12:29

One 450k trade deleted?

[moontheloon] 05/3/2024 12:19

And another ;) fomo

[moontheloon] 05/3/2024 10:51

There's the start

[wetdream] 05/3/2024 10:32

1.8m ‘buys’ and the share price doesn’t move….🤔;
This must be soaking up Amati’s last load.

[moontheloon] 05/3/2024 10:16

Volume is usually tell tale

[moontheloon] 05/3/2024 10:16

Strategic partner or insider knowledge .exciting times

[moontheloon] 05/3/2024 10:12

Now someone is building!

[sandy12345] 05/3/2024 10:07

Over 5p very soon

[moontheloon] 05/3/2024 09:44

Should see a tick up soon gentlemen and women who missed the 4p boat.

[moontheloon] 05/3/2024 08:30

The very professional guidance of a 30 year professional who has has had 5 successful sales of previous companies after improvement from within.

[moontheloon] 05/3/2024 08:29

ttps://www.voxmarkets.co.uk/articles/polarean-s-chris-von-jako-i-ve-been-bringing-new-and-important-life-changing-medical-technologies-to-market-for-30-years--30c3fc6/Vox Markets speaks to Chris von Jako, chief executive of Polarean), about the company’s five pillar strategy to drive uptake of its life saving lung imaging technology.0:29 Chris von Jako describes the progress the company’s made on the regulatory and commercial front since he joined as CEO last June.3:57 Discusses Chris’s 30 years of experience in overcoming the challenges of bringing new medical devices to market.6:54 Details of the company’s XENOVIEW technology, and how it offers clinicians a unique and highly effective approach lung diagnostics.11:14 Insurance support and other ways Polarean is planning to drive take up of the technology.13:44 The importance of partnerships as a route to market, and progress identifying new partners alongside Phillips15:13 Financing requirements for the five-pillar strategy and where it could take Polarean commercially.

[moontheloon] 05/3/2024 08:19

Ps someone has been steadily buying 250k chunks for a while now. Confidence is a preference. ;)

[moontheloon] 05/3/2024 08:05

Lol its lovely that you're still trying so hard to say you're not invested. Pathetic twins

[nigelpm] 04/3/2024 23:07

That's almost certainly why Amati walked.

They were clearly the wise ones here.

Nukem are gamblers and almost down 50% on their investment already at 6p.

Best scenario for equity now is modest dilution and hope takeup is quicker than board have laid out.

What a sorry state of affairs.

[goldbutler] 04/3/2024 21:59

The sales forecast from the Board of Directors (including Nukem) is just not good enough.

Polarean in a meeting ( utube 31 mins) feb 23 named 9 existing sites.
-4 for wave one and 5 wave 2 for sales.
That is a total of 9 and they now in their own words give installed forecast for 2025 of 12 maybe 14.

End of 2025

§ Total installed clinical base of 12 to 14 systems

So from years 2023 and 2024 and 2025 they will sell 3.

It simply isn't good enough from a board of directors with Nukem on board with a director running the company.

Have a look at the share price graph why would any board of directors wait until the share price is at the foot of the line graph at 4p to raise funds.

It isn't good enough from this Chairman and Board of Directors and they are not being held to account by UK investors.

[nigelpm] 04/3/2024 16:25

"An extraordinary 8 months of progress since you took the hot seat"

That made me laugh - remind me where the share price was back then?

[bones698] 04/3/2024 16:11

3p share raise or worse coming here don't listen to the trolls they will take their piece of the action at a discount for their investment and pis get shafted yet again here. Sp at all time lows don't get caught out this will drop when it's announce d

[moontheloon] 04/3/2024 11:04

Fantastic. Cvj got this

[epicsurf] 04/3/2024 10:41

ttps://www.voxmarkets.co.uk/articles/polarean-s-chris-von-jako-i-ve-been-bringing-new-and-important-life-changing-medical-technologies-to-market-for-30-years--30c3fc6/
Vox Markets speaks to Chris von Jako, chief executive of 

Polarean

 (POLX 

Follow

), about the company’s five pillar strategy to drive uptake of its life saving lung imaging technology.

0:29 Chris von Jako describes the progress the company’s made on the regulatory and commercial front since he joined as CEO last June.
3:57 Discusses Chris’s 30 years of experience in overcoming the challenges of bringing new medical devices to market.
6:54 Details of the company’s XENOVIEW technology, and how it offers clinicians a unique and highly effective approach lung diagnostics.
11:14 Insurance support and other ways Polarean is planning to drive take up of the technology.
13:44 The importance of partnerships as a route to market, and progress identifying new partners alongside Phillips
15:13 Financing requirements for the five-pillar strategy and where it could take Polarean commercially.

[moontheloon] 04/3/2024 09:50

It will be a different complexion with that commercial proof.

[moontheloon] 04/3/2024 09:49

There's 3 more conversions can drop anytime now. Keep the faith. ;)

[wetdream] 04/3/2024 09:35

Desirable by the clinicians - but they don’t have control over the budget.
Can’t understand why the company don’t come up with a less ‘painful’; way for hospitals to contract for the technology, to avoid the initial ‘hit’.

Imagine if finance didn’t exist for car buyers or house purchase!

[nigelpm] 03/3/2024 22:48

Just the reality of the situation gold - tech is simply not that desirable.

Very sad but true.